DR. CUSHMAN PUBLISHES PEER REVIEWED RESEARCH ARTICLE ON KEY NUTRACEUTICALS
Posted May 03 2012 12:00am
FOR IMMEDIATE RELEASE
A new peer reviewed article entitled “ Primary Risks of Oral Contraceptives and HRT ” discusses the benefits of two nutraceuticals- BRM4 and Plasmanex1, manufactured by Daiwa Pharmaceuticals, and researched by Dr. Gina Cushman in clinical practice.
(Newport Beach, CA) May 3, 2012- Gina Cushman, NMD, PhD, owner and founder of HealthBridge Medical Center and HealthBridge Management LLC in Newport Beach, CA has just been published in the peer reviewed Natural Medicine Journal, the official journal of the American Association of Naturopathic Physicians. She discusses ways to offset the primary risks that women face when taking hormone replacement therapy (HRT) and oral contraceptives (OC) prescribed by their physicians, including the use of 2 natural food extracts–Plasmanex1 and BRM4–one showing anticoagulant effects and the other exhibiting certain anti-inflammatory and immunomodulatory effects. Her discussion is based on the results of a clinical research study on the extracts, that was led by Dr. Cushman at her medical practice, and presented worldwide at three PharmCon peer-reviewed continuing medical education events on June 9th, 2011; July 7th, 2011; and August 10th, 2011.
“I am pleased to see that our team at HealthBridge was able to research these nutraceuticals in a real world medical practice setting, identifying a new and important application for the products, and then share the results of our research with thousands of physicians and pharmacists worldwide, through continuing medical education seminars and now through publication in a reputable peer-reviewed journal, “ says Dr. Cushman.
Long-term use of OCs and HRT have been linked to increased risks of cardiovascular problems, and chronic immune disorders with an inflammatory component, including cancer. The research study designed and led by Dr. Cushman investigated the clinical effects of the use of BRM4 (also referred to as BioBran, MGN3 or RBAC in some countries) and Plasmanex1 (NKCP) for the purpose of uncovering potential benefits of combined use, as well as areas that may prove fruitful for further research into ways to prevent serious side effects from OCs/HRT. The 6-week private practitioner research study included case study results that demonstrated the significant impact of these 2 extractsPlasmanex1 and BRM4on OC users and HRT users, with regard to offsetting thrombotic risk and improving inflammatory symptoms.
# # #
About HealthBridge Management LLC HealthBridge Management LLC is a nationally recognized consulting firm specializing in medical marketing, sales and distribution for the pharmaceutical and nutraceutical industries. HealthBridge delivers simple, affordable and doable medical sales, research and marketing solutions to meet the need, worldwide, for quality education, and access to effective pharmaceutical and nutraceutical products. For further information on our firm, partial client list and client comments, please visit www.HealthBridge.tv or call 949.612.9890.